Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | RXC004 |
Trade Name | |
Synonyms | RXC-004|RXC 004 |
Drug Descriptions |
RXC004 inhibits Porcupine (Porcn), thereby inhibits Wnt signaling, potentially resulting in tumor growth inhibition (J Clin Oncol 35, 2017 (suppl; abstr e14094)). |
DrugClasses | WNT Inhibitor 16 |
CAS Registry Number | NA |
NCIT ID | C156701 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Denosumab + Nivolumab + RXC004 | Denosumab Nivolumab RXC004 | 0 | 1 |
Denosumab + Pembrolizumab + RXC004 | Denosumab Pembrolizumab RXC004 | 0 | 1 |
Denosumab + RXC004 | Denosumab RXC004 | 0 | 2 |
Nivolumab + RXC004 | Nivolumab RXC004 | 0 | 1 |
RXC004 | RXC004 | 0 | 1 |